Duloxetine Versus Placebo for Fibromyalgia

Summary

The primary purpose of this study is to determine if duloxetine reduces pain severity in patients with fibromyalgia.

Timeline

Start

2002-11

Primary completion

—

Completion

2003-12

Outcome

Met primary endpoint

release “The antidepressant Cymbalta® (duloxetine HCl; pronounced sim-BAWL'-tuh), a dual-reuptake inhibitor of serotonin and norepinephrine, 60 mg once or twice daily, significantly reduced pain in more than half of women treated for fibromyalgia” lilly.com ↗

Drugs

Indications